1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Biosimilar of Remicade Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 100mg/10ml
  • 1.2.3 500mg/50ml
• 1.3 Market by Application
  • 1.3.1 Global Biosimilar of Remicade Market Share by Application: 2020 VS 2026
  • 1.3.2 Blood Disorders
  • 1.3.3 Oncology Diseases
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Biosimilar of Remicade Market Perspective (2015-2026)
• 2.2 Global Biosimilar of Remicade Growth Trends by Regions
  • 2.2.1 Biosimilar of Remicade Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Biosimilar of Remicade Historic Market Share by Regions (2015-2020)
  • 2.2.3 Biosimilar of Remicade Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Biosimilar of Remicade Players by Market Size
  • 3.1.1 Global Top Biosimilar of Remicade Players by Revenue (2015-2020)
  • 3.1.2 Global Biosimilar of Remicade Revenue Market Share by Players (2015-2020)
• 3.2 Global Biosimilar of Remicade Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Biosimilar of Remicade Revenue
• 3.4 Global Biosimilar of Remicade Market Concentration Ratio
  • 3.4.1 Global Biosimilar of Remicade Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Biosimilar of Remicade Revenue in 2019
• 3.5 Key Players Biosimilar of Remicade Area Served
• 3.6 Key Players Biosimilar of Remicade Product Solution and Service
• 3.7 Date of Enter into Biosimilar of Remicade Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Biosimilar of Remicade Breakdown Data by Type (2015-2026)

• 4.1 Global Biosimilar of Remicade Historic Market Size by Type (2015-2020)
• 4.2 Global Biosimilar of Remicade Forecasted Market Size by Type (2021-2026)

5 Biosimilar of Remicade Breakdown Data by Application (2015-2026)

• 5.1 Global Biosimilar of Remicade Historic Market Size by Application (2015-2020)
• 5.2 Global Biosimilar of Remicade Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Biosimilar of Remicade Market Size (2015-2026)
• 6.2 North America Biosimilar of Remicade Market Size by Type (2015-2020)
• 6.3 North America Biosimilar of Remicade Market Size by Application (2015-2020)
• 6.4 North America Biosimilar of Remicade Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Biosimilar of Remicade Market Size (2015-2026)
• 7.2 Europe Biosimilar of Remicade Market Size by Type (2015-2020)
• 7.3 Europe Biosimilar of Remicade Market Size by Application (2015-2020)
• 7.4 Europe Biosimilar of Remicade Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Biosimilar of Remicade Market Size (2015-2026)
• 8.2 China Biosimilar of Remicade Market Size by Type (2015-2020)
• 8.3 China Biosimilar of Remicade Market Size by Application (2015-2020)
• 8.4 China Biosimilar of Remicade Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Biosimilar of Remicade Market Size (2015-2026)
• 9.2 Japan Biosimilar of Remicade Market Size by Type (2015-2020)
• 9.3 Japan Biosimilar of Remicade Market Size by Application (2015-2020)
• 9.4 Japan Biosimilar of Remicade Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Biosimilar of Remicade Market Size (2015-2026)
• 10.2 Southeast Asia Biosimilar of Remicade Market Size by Type (2015-2020)
• 10.3 Southeast Asia Biosimilar of Remicade Market Size by Application (2015-2020)
• 10.4 Southeast Asia Biosimilar of Remicade Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Synthon Pharmaceuticals
  • 11.1.1 Synthon Pharmaceuticals Company Details
  • 11.1.2 Synthon Pharmaceuticals Business Overview
  • 11.1.3 Synthon Pharmaceuticals Biosimilar of Remicade Introduction
  • 11.1.4 Synthon Pharmaceuticals Revenue in Biosimilar of Remicade Business (2015-2020))
  • 11.1.5 Synthon Pharmaceuticals Recent Development
• 11.2 LG Life Sciences
  • 11.2.1 LG Life Sciences Company Details
  • 11.2.2 LG Life Sciences Business Overview
  • 11.2.3 LG Life Sciences Biosimilar of Remicade Introduction
  • 11.2.4 LG Life Sciences Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.2.5 LG Life Sciences Recent Development
• 11.3 Novartis (Sandoz)
  • 11.3.1 Novartis (Sandoz) Company Details
  • 11.3.2 Novartis (Sandoz) Business Overview
  • 11.3.3 Novartis (Sandoz) Biosimilar of Remicade Introduction
  • 11.3.4 Novartis (Sandoz) Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.3.5 Novartis (Sandoz) Recent Development
• 11.4 Celltrion
  • 11.4.1 Celltrion Company Details
  • 11.4.2 Celltrion Business Overview
  • 11.4.3 Celltrion Biosimilar of Remicade Introduction
  • 11.4.4 Celltrion Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.4.5 Celltrion Recent Development
• 11.5 Biocon
  • 11.5.1 Biocon Company Details
  • 11.5.2 Biocon Business Overview
  • 11.5.3 Biocon Biosimilar of Remicade Introduction
  • 11.5.4 Biocon Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.5.5 Biocon Recent Development
• 11.6 Hospira
  • 11.6.1 Hospira Company Details
  • 11.6.2 Hospira Business Overview
  • 11.6.3 Hospira Biosimilar of Remicade Introduction
  • 11.6.4 Hospira Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.6.5 Hospira Recent Development
• 11.7 Merck Serono (Merck Group)
  • 11.7.1 Merck Serono (Merck Group) Company Details
  • 11.7.2 Merck Serono (Merck Group) Business Overview
  • 11.7.3 Merck Serono (Merck Group) Biosimilar of Remicade Introduction
  • 11.7.4 Merck Serono (Merck Group) Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.7.5 Merck Serono (Merck Group) Recent Development
• 11.8 Biogen idec Inc.
  • 11.8.1 Biogen idec Inc. Company Details
  • 11.8.2 Biogen idec Inc. Business Overview
  • 11.8.3 Biogen idec Inc. Biosimilar of Remicade Introduction
  • 11.8.4 Biogen idec Inc. Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.8.5 Biogen idec Inc. Recent Development
• 11.9 Genentech (Roche Group)
  • 11.9.1 Genentech (Roche Group) Company Details
  • 11.9.2 Genentech (Roche Group) Business Overview
  • 11.9.3 Genentech (Roche Group) Biosimilar of Remicade Introduction
  • 11.9.4 Genentech (Roche Group) Revenue in Biosimilar of Remicade Business (2015-2020)
  • 11.9.5 Genentech (Roche Group) Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer

Global Biosimilar of Remicade Scope and Market Size
Biosimilar of Remicade market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Biosimilar of Remicade market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
100mg/10ml
500mg/50ml

Market segment by Application, split into
Blood Disorders
Oncology Diseases

Based on regional and country-level analysis, the Biosimilar of Remicade market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Biosimilar of Remicade market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Synthon Pharmaceuticals
LG Life Sciences
Novartis (Sandoz)
Celltrion
Biocon
Hospira
Merck Serono (Merck Group)
Biogen idec Inc.
Genentech (Roche Group)